W S Colucci, R F Wright, E Braunwald. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterAdministration, OralAminopyridines/administration & dosageAminopyridines/pharmacologyAminopyridines/therapeutic useAmrinoneCardiotonic Agents/pharmacologyCardiotonic Agents/therapeutic useCoenzymesEnoximoneHeart/drug effectsHeart Failure/drug therapyHemodynamics/drug effectsHumansImidazoles/pharmacologyImidazoles/therapeutic useInjections, IntravenousMilrinoneNifedipine/analogs & derivativesNifedipine/therapeutic useOxyfedrine/analogs & derivativesOxyfedrine/therapeutic usePhosphodiesterase Inhibitors/pharmacologyPhosphodiesterase Inhibitors/therapeutic usePyridazines/therapeutic usePyridones/administration & dosagePyridones/pharmacologyPyridones/therapeutic useQuinazolines/pharmacologyQuinazolines/therapeutic useUbiquinone/analogs & derivativesUbiquinone/therapeutic use
Substances: See more » AminopyridinesCardiotonic AgentsCoenzymesImidazolesPhosphodiesterase InhibitorsPyridazinesPyridonesQuinazolinesUbiquinonepiroximonepimobendan3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterEnoximonequazinoneOxyfedrinecoenzyme Q10sulmazoleNifedipineMilrinoneAmrinonealifedrine
Year: 1986 PMID: 2418353 DOI: 10.1056/NEJM198602063140605
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245